跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Obesity therapeutic
首页
药物
Obesity therapeutic
Obesity therapeutic
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
A LEPTIN RECEPTOR AGONIST ANTIBODY FOR USE IN INCREASING BONE MASS IN A SUBJECT SUFFERING FROM METABOLIC DYSFUNCTION OR HYPOLEPTINEMIA
EP 3773713 B1
申请人: REGENERON PHARMA
优先权: 2018
CN
EP
US
WO
10 件公开
THERAPEUTIC OR PROPHYLACTIC METHOD FOR DIABETES USING COMBINATION MEDICINE
EP 4026564 A4
申请人: JAPAN TOBACCO INC
优先权: 2019
CN
EP
US
WO
5 件公开
METHODS AND COMPOSITIONS FOR TREATING OBESITY
EP 1774028 A4
申请人: DANA FARBER CANCER INST INC
优先权: 2004
EP
US
WO
4 件公开
OBESITY ANIMAL MODEL AND METHODS FOR MAKING AND USING THEREOF
US 2015208620 A1
申请人: UNIV SHANGHAI JIAOTONG
优先权: 2012
EP
US
WO
4 件公开
Novel genes and their use in the modulation of obesity, diabetes and energy imbalance
US 2006155111 A9
申请人: AUTOGEN RES PTY LTD
优先权: 2000
US
4 件公开
Triazole compounds and uses related thereto
US 7683059 B2
申请人: AMGEN INC
优先权: 2004
US
4 件公开
Arylsulfones and uses related thereto
US 7402704 B2
申请人: AMGEN INC
优先权: 2005
US
4 件公开
Arylsulfonamides and uses related thereto
US 7495012 B2
申请人: AMGEN INC
优先权: 2005
US
4 件公开
PHARMACEUTICAL COMPOSITION COMPRISING A TRIPLE-ACTIVATOR PERSISTENT CONJUGATE AS ACTIVE INGREDIENT
EP 4197560 A1
申请人: HANMI PHARM IND CO LTD
优先权: 2020
EP
US
WO
3 件公开
Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
US 9655865 B2
申请人: CINCOTTA ANTHONY H
优先权: 2008
CN
US
3 件公开
US 2013274246 A1
申请人: CINCOTTA ANTHONY H
优先权: 2011
CN
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈